EBV-associated hemophagocytic lymphohistiocytosis with spontaneous regression [5]

Indian Pediatrics

Volumn 42, Issue 12, 2005, Pages 1253-1255

  Bakhshi, Sameer ^a   Pautu, Jeremy L ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN A; CYTOTOXIC AGENT; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT; STEROID;

CASE REPORT; CELL PROLIFERATION; CLINICAL FEATURE; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATITIS; HEPATOMEGALY; HUMAN; LABORATORY TEST; LETTER; MALE; PHYSICAL EXAMINATION; REMISSION; SCHOOL CHILD; SPLENOMEGALY;

CHILD; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; REMISSION, SPONTANEOUS;

EID: 32644434048     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Imashuku S. Advances in the management of Hemophagocytic Lymphohistiocytosis. Inter J Hematol 2000; 72: 1-11.
2. Janka GE, Imashuku S, Elinder G, Schneider M, Henter JI. Infection and malignancy associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998; 12: 435-444.
3. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991; 18: 29 -33.
4. Janka GE, Schneider EM. Modem management of children with hemophagocytic lymphohistio-cytosis. Br J Hematol 2004; 124: 4-14.
5. Imashuku S, Hibi S, Ohara T, Iwai A, Sake M, Kato M, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999; 93: 1869-1874.